Published in Women's Health Weekly, November 4th, 2004
The program, called BOADICEA (Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm), uses detailed family history to predict a woman's risk of developing cancer. It improves on previous programs because it takes into account genetic mutations besides those of the well-known BRCA1 and BRCA2 genes.
The researchers plan to offer BOADICEA to health professionals to help them pre-select women likely to be at high risk for further testing, and sparing others the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.